Rykindo Kit
Product Images NDC 72526-104

Product Visual Gallery

This gallery contains 57 technical images submitted to the FDA as part of the official labeling for Rykindo (NDC 72526-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Shandong Luye Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Rykindo 01)

An instructional diagram showing components of the Rykindo extended-release microspheres kit by Shandong Luye Pharmaceutical Co., Ltd. It includes labeled illustrations of a vial adapter with luer opening, spike tip, and skirt; a prefilled syringe with plunger rod, diluent, translucent gray cap, and LUER-LOK adapter; a vial containing powder with colored cap; and an injection needle with needle protector and needle safety device.*

FDA Label Image

Figure (Rykindo 02)

An instructional illustration showing a rectangular box and a clock icon indicating a 30-minute duration. The image suggests timing or waiting for 30 minutes related to the product kit usage.*

FDA Label Image

Figure (Rykindo 03)

An instructional illustration showing a vial being opened by lifting or removing its cap. The image depicts a hand holding the vial and another hand removing the cap, indicating the first step in accessing the contents of the vial.*

FDA Label Image

Figure (Rykindo 04)

An instructional diagram showing a person using a kit to prepare or administer a dose of Rykindo extended-release microspheres (risperidone). The image depicts hands manipulating the device, likely illustrating part of the medication preparation or injection process for this prescription drug kit by Shandong Luye Pharmaceutical Co., Ltd.*

FDA Label Image

Figure (Rykindo 05)

An instructional diagram showing a hand pressing down on the cap of a vial or container, with an arrow indicating downward pressure. The gesture appears to demonstrate how to open or activate the vial, likely related to Rykindo extended-release microspheres medication kit.*

FDA Label Image

Figure (Rykindo 06)

An instructional illustration depicting the incorrect technique for handling or administering a product. The image features a hand holding a vial or syringe with a large X symbol and the word "Incorrect" indicating the shown method should be avoided. No specific product details are visible in the image.*

FDA Label Image

Figure (Rykindo 07)

An instructional diagram showing the opening of a container or vial as part of preparing a medication dose. The illustration depicts one hand holding the container and another hand lifting or removing a cap, with an arrow indicating the direction to pull upwards.*

FDA Label Image

Figure (Rykindo 08)

Instructional text advising to remove the vial adapter from the sterile blister only when ready to remove the translucent gray cap from the prefilled syringe.*

FDA Label Image

Figure (Rykindo 09)

An instructional line drawing showing a hand holding a small vial or container, illustrating how to grip the product, likely related to the administration or preparation of Rykindo extended-release microspheres kit by Shandong Luye Pharmaceutical Co., Ltd.*

FDA Label Image

Figure (Rykindo 10)

An instructional illustration showing a hand holding a small item incorrectly, indicated by a yellow box with an 'X' and the word 'Incorrect' above the hand. The image likely pertains to proper handling or usage guidance for Rykindo extended-release microspheres kit by Shandong Luye Pharmaceutical Co., Ltd.*

FDA Label Image

Figure (Rykindo 11)

An instructional illustration showing two hands manipulating medication components. One hand holds a small vial, and the other hand holds a different piece, possibly a cap or applicator, positioned to be attached or combined with the vial. The image likely demonstrates part of the preparation or administration process for Rykindo extended-release microspheres kit by Shandong Luye Pharmaceutical Co., Ltd.*

FDA Label Image

Figure (Rykindo 12)

An instructional diagram showing a syringe after the cap has been removed. The syringe is depicted horizontally with a plunger on the left and needle covered by a protective shield on the right. Below the image is a text instruction stating, "When the cap is removed, the syringe will look like this." It appears related to Rykindo extended-release microspheres kit by Shandong Luye Pharmaceutical Co., Ltd.*

FDA Label Image

Figure (Rykindo 13)

An instructional diagram showing a hand holding a vial while another hand inserts a syringe into the vial's stopper. Arrows indicate twisting the vial cap and pushing the syringe downward, demonstrating how to prepare the Rykindo extended-release microspheres kit for use.*

FDA Label Image

Figure (Rykindo 14)

An instructional diagram showing a hand holding a syringe positioned above a small vial, with an arrow pointing downward indicating the syringe should be inserted into the vial. This likely demonstrates the preparation step for the Rykindo extended-release microspheres kit.*

FDA Label Image

Figure (Rykindo 15)

Text panel warning that vial contents are now under pressure and instructing to keep holding the plunger rod down with thumb.*

FDA Label Image

Figure (Rykindo 16)

An instructional diagram illustrating the proper technique for using a syringe or injector device. It shows a hand holding and pressing the device downward, with a circular dose indicator displaying '30 mg/0.4 ml' in yellow and black, and directional arrows indicating movement for administration.*

FDA Label Image

Figure (Rykindo 17)

An instructional illustration showing a hand holding a vial above a syringe with the syringe tip inserted into the vial. A downward arrow indicates the direction for drawing liquid from the vial into the syringe, demonstrating proper technique for medication preparation.*

FDA Label Image

Figure (Rykindo 18)

An instructional illustration showing a hand holding a syringe with its cap being removed or prepared for use, indicating the step of removing or attaching a cap by pulling in the direction of an arrow. This image is related to the preparation or administration process of Rykindo extended-release microspheres kit by Shandong Luye Pharmaceutical Co., Ltd.*

FDA Label Image

Figure (Rykindo 19)

An instructional diagram showing the administration of Rykindo extended-release microspheres via intramuscular injection in the buttock area. The illustration includes a depiction of the injection site on the lower back/upper buttock and a detailed view of the injection device with a needle and syringe.*

FDA Label Image

Figure (Rykindo 20)

An instructional diagram showing hands demonstrating the use of a tool to twist and open a component, likely part of the administration or preparation process for a medication kit. The image indicates a rotational motion with arrows and a close-up of the twisting action.*

FDA Label Image

Figure (Rykindo 21)

An instructional illustration showing a hand gripping and moving a device or component up and down, indicated by two arrows pointing upward and downward. This likely demonstrates a step in the use or preparation of the Rykindo extended-release microspheres kit.*

FDA Label Image

Figure (Rykindo 22)

An instructional black and white illustration showing hands manipulating a device or tool with arrows indicating movement directions. This figure likely demonstrates a step in the use or assembly of the Rykindo extended-release microspheres kit by Shandong Luye Pharmaceutical Co., Ltd.*

FDA Label Image

Figure (Rykindo 23)

Instructional diagram showing how to use a syringe with extended-release microspheres. The illustration depicts a hand holding a syringe and another hand pulling off a protective cap by pulling upward, indicated by an arrow.*

FDA Label Image

Figure (Rykindo 24)

An instructional illustration showing the lower torso and buttocks of a person viewed from behind, with a bold black arrow pointing to the upper outer quadrant of the gluteal region, indicating the preferred site for intramuscular injection.*

FDA Label Image

Figure (Rykindo 25)

An instructional diagram showing a hand breaking the tip of a cap or applicator by snapping it off, indicated by an arrow. An inset circle zooms in on the broken tip labeled 'AFTER,' illustrating the removal process, likely part of the preparation for using Rykindo extended-release microspheres kit.*

FDA Label Image

Figure (Rykindo 26)

An instructional illustration showing a person disposing of a syringe by placing it into a closed biohazard sharps disposal container with a lid. The container is marked with a biohazard symbol on the front, indicating safe disposal of sharps waste.*

FDA Label Image

Chemical Structure (Rykindo 27)

Chemical structure diagram of risperidone, the active ingredient in Rykindo extended-release microspheres. The diagram shows the molecule's ring systems, including a piperidine ring, a benzisoxazole moiety with a fluorine substituent, and other key structural features.*

FDA Label Image

Figure (Rykindo 28)

Illustration of the components of a Rykindo extended-release microspheres injection kit, including a vial adapter with luer opening, spike tip, and skirt; a prefilled syringe with plunger rod, diluent, translucent gray cap, and luer-lok adapter; a vial containing powder with a colored cap; and an injection needle with needle protector and needle safety device.*

FDA Label Image

Figure (Rykindo 29)

An instructional illustration showing a rectangular box with a clock symbol indicating a 30-minute time interval highlighted in yellow on the clock face.*

FDA Label Image

Figure (Rykindo 30)

An instructional illustration showing hands opening a vial by removing the rubber stopper with a circular cap being lifted upwards. The image demonstrates the correct method to access the contents inside a vial, likely part of the administration steps for a medication kit.*

FDA Label Image

Figure (Rykindo 31)

An instructional illustration showing hands holding and inserting a device, likely demonstrating how to administer or prepare Rykindo extended-release microspheres kit.*

FDA Label Image

Figure (Rykindo 32)

An instructional illustration showing a hand preparing a medication vial with a stopper, demonstrating the pressing or pushing down on the stopper. It likely depicts a step in the preparation or administration process for the Rykindo extended-release microspheres kit by Shandong Luye Pharmaceutical Co., Ltd.*

FDA Label Image

Figure (Rykindo 33)

Illustration showing incorrect usage of a medication administration device, highlighting a hand holding a vial or ampule inserted improperly into a larger device. Labeled with an 'X' and the word 'Incorrect' to caution the user against this method.*

FDA Label Image

Figure (Rykindo 34)

Instructional illustration showing the removal of a cap from a vial, with a hand pulling the cap upwards. The image is likely part of usage directions for Rykindo extended-release microspheres.*

FDA Label Image

Figure (Rykindo 35)

An instructional warning box advising to remove the vial adapter from the sterile blister only when ready to remove the translucent gray cap from the prefilled vial. The text is clear and set on a white background with a caution symbol.*

FDA Label Image

Figure (Rykindo 36)

An instructional illustration showing a hand gripping a small vial or container, likely demonstrating how to hold or prepare the product for use. The vial appears to be part of a kit, consistent with the Rykindo extended-release microspheres packaging.*

FDA Label Image

Figure (Rykindo 37)

An instructional diagram showing a hand holding a dosing device incorrectly, marked with an 'X' and labeled 'Incorrect.' The image is intended to demonstrate improper usage technique for the Rykindo extended-release microspheres kit by Shandong Luye Pharmaceutical Co., Ltd.*

FDA Label Image

Figure (Rykindo 38)

An instructional line drawing depicting a person holding two small components, illustrating the process of assembling or connecting them by aligning one part with the other. The image likely demonstrates a step in preparing the Rykindo extended-release microspheres kit for use.*

FDA Label Image

Figure (Rykindo 39)

An instructional illustration showing a syringe from the Rykindo extended-release microspheres kit by Shandong Luye Pharmaceutical Co., Ltd. The syringe is depicted with the cap removed, demonstrating its appearance after cap removal.*

FDA Label Image

Figure (Rykindo 40)

An instructional illustration showing the preparation of a medication kit involving a syringe and vial. It depicts one hand holding the vial while the other hand twists the syringe to attach it, with arrows indicating twisting and downward motion directions.*

FDA Label Image

Figure (Rykindo 41)

An instructional illustration showing a hand holding a syringe above a vial with another hand stabilizing the vial. A downward arrow indicates inserting the syringe into the vial, demonstrating the preparation of a dose for Rykindo extended-release microspheres kit by Shandong Luye Pharmaceutical Co., Ltd.*

FDA Label Image

Figure (Rykindo 42)

An instructional warning panel stating: "Vial contents will now be under pressure. Keep holding the plunger rod down with thumb." This guidance is likely part of usage instructions for Rykindo extended-release microspheres kit.*

FDA Label Image

Figure (Rykindo 43)

An instructional diagram showing a hand holding a syringe attached to a vial. The illustration emphasizes rotating or mixing the vial, indicated by a circular arrow and a clock image showing a 30-second interval. It likely demonstrates preparation steps for Rykindo extended-release microspheres kit by Shandong Luye Pharmaceutical Co., Ltd.*

FDA Label Image

Figure (Rykindo 44)

An instructional illustration showing a hand attaching or preparing a syringe or injection device. An arrow indicates a downward motion guiding the assembly or operation. This image likely depicts a step in preparing the Rykindo extended-release microspheres kit for administration.*

FDA Label Image

Figure (Rykindo 45)

An instructional diagram showing the process of mixing medication from a vial into a syringe. The illustration emphasizes consistent agitation by rolling the vial before drawing the liquid into the syringe, likely intended for preparing Rykindo extended-release microspheres kit.*

FDA Label Image

Figure (Rykindo 46)

An instructional illustration showing the method of intramuscular injection in the buttock area. The image also includes a depiction of a prefilled syringe or injection device, likely related to the administration of Rykindo extended-release microspheres (Risperidone) kit by Shandong Luye Pharmaceutical Co., Ltd.*

FDA Label Image

Figure (Rykindo 47)

An instructional illustration showing hands opening a package by peeling back a flap, indicating the direction to open with a curved arrow.*

FDA Label Image

Figure (Rykindo 48)

An instructional illustration showing a hand gripping and moving a stick-like object up and down, indicated by two black arrows pointing in opposite directions along the shaft. This image appears to demonstrate a usage or administration technique related to the Rykindo extended-release microspheres kit.*

FDA Label Image

Figure (Rykindo 49)

An instructional illustration showing hands operating a device, with arrows indicating movement directions. One hand presses a lever downwards while the other hand pulls or slides a component to the right, likely demonstrating part of the use or assembly process for the Risperidone extended-release microspheres kit by Shandong Luye Pharmaceutical Co., Ltd.*

FDA Label Image

Figure (Rykindo 50)

An instructional illustration showing two hands preparing a syringe. One hand holds the syringe while the other pulls back on a plunger or stopper, indicated by an upward arrow, demonstrating how to prepare or activate the syringe before administration.*

FDA Label Image

Figure (Rykindo 51)

An illustration showing the lower back and buttocks of a human figure, with a black arrow pointing to the gluteal area, indicating injection site or application location relevant to medication administration.*

FDA Label Image

Figure (Rykindo 52)

An instructional diagram showing the step of tearing open a package or strip. The image includes a close-up inset indicating how to properly tear or open the item by pulling at a designated point.*

FDA Label Image

Figure (Rykindo 53)

An illustration shows a hand holding a dropper above an open biohazard sharps disposal container. The image suggests proper disposal of liquid or small medical waste into the container with a biohazard symbol on the front.*

FDA Label Image

Principal Display Panel (12.5 mg Kit Carton)

Rykindo 12.5 mg Kit packaging label for risperidone extended-release injectable suspension by Shandong Luye Pharmaceutical Co., Ltd. The label includes kit contents, single dose instructions for gluteal intramuscular injection, storage directions to keep the kit refrigerated, and a note to read complete instructions prior to use.*

FDA Label Image

Principal Display Panel (25 mg Kit Carton)

Rykindo 25 mg kit packaging label for risperidone extended-release injectable suspension by Shandong Luye Pharmaceutical Co., Ltd. The label states it is for gluteal intramuscular injection only, includes one 25 mg vial of risperidone suspension, a pre-filled syringe with 2 mL diluent, a vial adapter, and a 20-gauge safety needle. It is a single-dose prescription product to be stored in a refrigerator.*

FDA Label Image

Principal Display Panel (37.5 mg Kit Carton)

Box packaging label for Rykindo 37.5 mg kit, an extended-release injectable suspension of risperidone. The label indicates the kit contains one 37.5 mg vial, a pre-filled syringe with diluent, a vial adapter, and a safety needle for gluteal intramuscular injection. The product is labeled for single-dose use by Shandong Luye Pharmaceutical Co., Ltd.*

FDA Label Image

Principal Display Panel (50 mg Kit Carton)

Packaging label for Rykindo 50 mg kit, an extended-release injectable suspension containing risperidone. The box indicates it is for gluteal intramuscular injection only and includes a single dose kit with one 50 mg vial of risperidone, a pre-filled syringe with 2 mL diluent, one vial adapter, and a 20-gauge safety needle. Labeler is Shandong Luye Pharmaceutical Co., Ltd.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.